| Q34141083 | A Common Haplotype in NAPEPLD Is Associated With Severe Obesity in a Norwegian Population‐Based Cohort (the HUNT Study) |
| Q35222170 | A locus on mouse Chromosome 9 (Adip5) affects the relative weight of the gonadal but not retroperitoneal adipose depot |
| Q40974696 | Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance |
| Q37347715 | Acute effect of infection by adipogenic human adenovirus Ad36. |
| Q37080092 | Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin |
| Q30587153 | Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety |
| Q29620456 | Adipokines in inflammation and metabolic disease |
| Q38139293 | Adipose tissue inflammation in glucose metabolism |
| Q91994660 | Analysis of genes linked to depressive-like behaviors in interleukin-18-deficient mice: Gene expression profiles in the brain |
| Q98613140 | Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis |
| Q47139364 | Are IL18RAP gene polymorphisms associated with body mass regulation? A cross-sectional study |
| Q36287002 | Association of interleukin-18 gene polymorphism with body mass index in women |
| Q37141763 | Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis |
| Q36381096 | Biomarkers of obesity and subsequent cardiovascular events |
| Q47661727 | COPs and POPs Patrol Inflammasome Activation |
| Q93007803 | CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice |
| Q33595895 | Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging |
| Q90114942 | Caspase-1 as a regulatory molecule of lipid metabolism |
| Q38187337 | Caspases and inflammasomes in metabolic inflammation |
| Q35829203 | Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns |
| Q35861003 | Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue |
| Q34573680 | Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome |
| Q33652307 | Circulating levels of interleukin-1 family cytokines in overweight adolescents. |
| Q35968506 | Common STAT3 variants are not associated with obesity or insulin resistance in female twins |
| Q46367558 | Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain. |
| Q51745836 | Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. |
| Q38100529 | Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples |
| Q90678059 | Cytokines and inflammation in adipogenesis: an updated review |
| Q28480545 | Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection |
| Q59330135 | Deficiency in interleukin-18 promotes differentiation of brown adipose tissue resulting in fat accumulation despite dyslipidemia |
| Q39898733 | Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. |
| Q35900629 | Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice |
| Q38294300 | Diet, behavior and immunity across the lifespan. |
| Q54731039 | Differential haplotypic expression of the interleukin-18 gene. |
| Q43136613 | Divergent responses to thermogenic stimuli in BAT and subcutaneous adipose tissue from interleukin 18 and interleukin 18 receptor 1-deficient mice |
| Q36692476 | Dysregulation of maternal serum adiponectin in preterm labor |
| Q85028058 | Edentulism associated with obesity: a study of four national surveys of 16 416 Swedes aged 55–84 years |
| Q36349767 | Effect of Weight-Reduction in Obese Mice Lacking Toll-Like Receptor 5 and C57BL/6 Mice Fed a Low-Fat Diet |
| Q33810797 | Effects of body weight and alcohol consumption on insulin sensitivity |
| Q35189080 | Endogenous interleukin 18 suppresses hyperglycemia and hyperinsulinemia during the acute phase of endotoxemia in mice. |
| Q30482887 | Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet |
| Q36405704 | Endurance and Resistance Training Affect High Fat Diet-Induced Increase of Ceramides, Inflammasome Expression, and Systemic Inflammation in Mice |
| Q27321681 | Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis |
| Q33689422 | Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. |
| Q53691097 | Female sex hormones are necessary for the metabolic effects mediated by loss of Interleukin 18 signaling. |
| Q37143708 | Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes |
| Q35172378 | Genetic variation within IL18 is associated with insulin levels, insulin resistance and postprandial measures |
| Q34708047 | Historical insights into cytokines |
| Q39194536 | Hypothalamic neuronal toll-like receptor 2 protects against age-induced obesity |
| Q52582325 | IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies. |
| Q36005876 | IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance |
| Q34763727 | IL-18 is required for self-reactive T cell expansion in NOD mice |
| Q58802853 | IL-37 Expression Reduces Lean Body Mass in Mice by Reducing Food Intake |
| Q54325530 | IL-37 protects against obesity-induced inflammation and insulin resistance. |
| Q38192633 | Immune and inflammatory pathways in NASH. |
| Q44786716 | Immunological complications of obesity |
| Q42226733 | Immunomodulatory factors and infectious agents associated with the hepatic gene expression of the IGF system in nursery pigs |
| Q34024277 | Increased beta-cell mass by islet transplantation and PLAG1 overexpression causes hyperinsulinemic normoglycemia and hepatic insulin resistance in mice |
| Q37377709 | Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling |
| Q35044541 | Increased expression of IL-18 in the serum and islets of type 1 diabetics |
| Q46506826 | Increased fat:carbohydrate oxidation ratio in Il1ra (-/-) mice on a high-fat diet is associated with increased sympathetic tone |
| Q35216914 | Inflammasome is a central player in the induction of obesity and insulin resistance |
| Q90701009 | Inflammasome signaling and regulation of interleukin-1 family cytokines |
| Q28512778 | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity |
| Q57492010 | Inflammasome: A Double-Edged Sword in Liver Diseases |
| Q28389531 | Inflammasomes and metabolic disorders: old genes in modern diseases |
| Q29616356 | Inflammasomes in health and disease |
| Q47593693 | Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts |
| Q60303389 | Inflammasomes: Pandora's box for sepsis |
| Q37995069 | Inflammasomes: far beyond inflammation |
| Q27001186 | Inflammasomes: mechanism of action, role in disease, and therapeutics |
| Q37174503 | Inflammation during obesity is not all bad: evidence from animal and human studies |
| Q28066646 | Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications |
| Q35838041 | Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans |
| Q36409227 | Inflammatory mechanisms in the regulation of insulin resistance |
| Q47149968 | Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18. |
| Q28771509 | Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter |
| Q34095673 | Interleukin 18 in the CNS. |
| Q26778553 | Interleukin-1 Family Cytokines in Liver Diseases |
| Q61911892 | Interleukin-15 Contributes to the Regulation of Murine Adipose Tissue and Human Adipocytes |
| Q37110553 | Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice |
| Q37220336 | Interleukin-18 and IL-18 binding protein |
| Q35865066 | Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency |
| Q42817301 | Interleukin-18 enhances glucose uptake in 3T3-L1 adipocytes |
| Q64275741 | Interleukin-18 in Health and Disease |
| Q42258755 | Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse |
| Q34450892 | Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice |
| Q38685111 | Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study. |
| Q81681379 | Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus |
| Q40720751 | Interleukin-18-deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis. |
| Q47285927 | Interleukin-18: Biological properties and role in disease pathogenesis |
| Q34626217 | Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice |
| Q93133573 | Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction |
| Q90101165 | Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue |
| Q60472237 | Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults |
| Q36128155 | Interleukin-7 Plasma Levels in Human Differentiate Anorexia Nervosa, Constitutional Thinness and Healthy Obesity. |
| Q34328873 | Interleukin-7 regulates adipose tissue mass and insulin sensitivity in high-fat diet-fed mice through lymphocyte-dependent and independent mechanisms |
| Q33550810 | Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation. |
| Q36854344 | Interplay of pro- and anti-inflammatory cytokines to determine lipid accretion in adipocytes |
| Q83379079 | Linking the inflammasome to obesity-related disease |
| Q36373163 | Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes |
| Q56951980 | Liver repercussions of defective gut surveillance |
| Q41879714 | Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice. |
| Q36119524 | Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance |
| Q48226767 | Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy |
| Q37695121 | Lower NLRP3 inflammasome activity in NAG-1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity |
| Q21144671 | Malnutrition and infection: complex mechanisms and global impacts |
| Q37350317 | Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain |
| Q42194619 | Matching experiments across species using expression values and textual information |
| Q42546120 | Membrane interleukin-18 revisits membrane IL-1α in T-helper type 1 responses |
| Q27336723 | Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis |
| Q34608360 | Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-induced obesity and insulin resistance |
| Q91963050 | Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes |
| Q58316591 | Molecular Definition of Inflammasomes |
| Q60959905 | NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development |
| Q90262460 | NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling |
| Q37212058 | Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse |
| Q35641956 | Night eating and obesity in the EP3R-deficient mouse |
| Q90288099 | Nlrp1b1 negatively modulates obesity-induced inflammation by promoting IL-18 production |
| Q33580624 | Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease |
| Q50978244 | Obesity development in caspase-1-deficient mice. |
| Q22250939 | Obesity, Inflammation, and Insulin Resistance |
| Q47285878 | Overview of the IL-1 family in innate inflammation and acquired immunity |
| Q54260312 | Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications. |
| Q35813603 | Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy |
| Q50420493 | Physiological and molecular effects of interleukin-18 administration on the mouse kidney. |
| Q85184151 | Pitavastatin Reduces Elevated IL-18 Levels in Japanese Subjects with Hypercholesterolemia: Sub-analysis of Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) |
| Q90244453 | Polyglycolic acid sutures embedded in abdominal acupoints for treatment of simple obesity in adults: a randomized control trial |
| Q33908725 | Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation |
| Q90599568 | Pyroptosis in Liver Disease: New Insights into Disease Mechanisms |
| Q26739753 | Questions and controversies in innate immune research: what is the physiological role of NLRP3? |
| Q58692657 | Regulation of Energy Expenditure and Brown/Beige Thermogenic Activity by Interleukins: New Roles for Old Actors |
| Q95643265 | Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies |
| Q36712641 | Role of caspase-1 in regulation of triglyceride metabolism. |
| Q28300967 | Role of the HIN domain in regulation of innate immune responses |
| Q37925073 | Sensing damage by the NLRP3 inflammasome |
| Q37505460 | Session on 'Obesity'. Adipose tissue development, nutrition in early life and its impact on later obesity. |
| Q36885097 | Signals generating anorexia during acute illness |
| Q40928068 | Sirtuin-1 is a nutrient-dependent modulator of inflammation |
| Q35001511 | Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives |
| Q35976791 | The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue |
| Q55401263 | The Effects of Sinapic Acid on the Development of Metabolic Disorders Induced by Estrogen Deficiency in Rats. |
| Q39793088 | The Proinflammatory Cytokine Interleukin 18 Regulates Feeding by Acting on the Bed Nucleus of the Stria Terminalis. |
| Q33861166 | The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat. |
| Q34897067 | The effects of erythropoietin dose titration during high-fat diet-induced obesity |
| Q36686713 | The frequency of an IL-18-associated haplotype in Africans |
| Q36387304 | The hormonal control of food intake |
| Q36931760 | The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity |
| Q24613816 | The inflammasome: in memory of Dr. Jurg Tschopp |
| Q34391415 | The interleukin-1 family: back to the future |
| Q35017018 | The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro |
| Q26852901 | The role of adipokines in chronic inflammation |
| Q28730838 | The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy |
| Q33304007 | The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus |
| Q33804391 | The role of interleukin-18 in the metabolic syndrome |
| Q37462159 | The role of interleukins in insulin resistance and type 2 diabetes mellitus. |
| Q33331801 | The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice |
| Q24657048 | The role of the vgf gene and VGF-derived peptides in nutrition and metabolism |
| Q37796144 | Toll-like receptors: linking inflammation to metabolism |
| Q47589398 | Tuberculosis and host metabolism: ancient associations, fresh insights |
| Q59138098 | Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways |
| Q37286991 | Why is obesity associated with osteoarthritis? Insights from mouse models of obesity |
| Q42853651 | −607 C/A polymorphism in the promoter of IL-18 gene is associated with 2 h post-loading plasma glucose level in Chinese |